Valeant Pharmaceuticals International (NYSE:VRX)

ChipNPutt11 (63.10) Submitted: 4/29/2013 4:11:33 PM : Start Price: $74.96 VRX Score: -4.36

Great management. Wonderful pruduct line, all be it mainly through acqusitions. Specialize in topical ointments. do a great job integrating acqs. Just run by a bunch of really smart guys,, easy to understand pharma. products. Expanding R&D and facility in Westchester County, people like working there!

LongShortIndex (33.07) Submitted: 3/22/2013 2:07:26 AM : Start Price: $72.57 VRX Score: +3.95

sell vrx
buy cbst

TMFRazorback (90.33) Submitted: 4/19/2012 12:09:27 PM : Start Price: $53.75 VRX Score: +20.84

This is a great, low-risk pharma business with awesome prospects for high growth. Management invests very little in R&D. Instead they look to buy established, small, niche biotech businesses at single-digit multiples to free cash flow. These biotech's are usually poorly managed which is why they get to buy them at such a ridiculously low price. Valeant then fixes them up to a higher performance level where they can either continue to milk it for cash flow or sell it to another pharma company at a higher valuation than what Valeant paid. It's a wonderful formula that is working extremely well for them. They mention in their annual letter that all assets are available for sale at all times at the right price.

The stock right now trades for less than 15 times forward earnings -- a very cheap price to pay for additional acquisitions and growth. Also, this is Sequoia Fund's largest holding.

TMFBrich (86.59) Submitted: 3/12/2012 3:53:42 PM : Start Price: $54.55 VRX Score: +16.61

CFO insider buying, as outlined in this article: http://www.fool.com/investing/general/2012/03/12/the-surprising-signal-that-provides-superior-infor.aspx.

UnstableEnabled (< 20) Submitted: 3/9/2012 1:41:56 AM : Start Price: $55.48 VRX Score: +14.09

Valeant has been making me money for over a year now. Love it!

Retire20150 (63.35) Submitted: 9/23/2011 10:26:10 PM : Start Price: $38.33 VRX Score: +50.45

Generics are en vogue.

LordDividend (37.40) Submitted: 5/4/2011 10:59:34 AM : Start Price: $48.69 VRX Score: +30.63

Who will the CEO target next?

thunderhawke23 (< 20) Submitted: 3/30/2011 10:17:51 AM : Start Price: $48.84 VRX Score: +28.02

strong CEO

outsidernone (< 20) Submitted: 12/1/2010 3:02:15 PM : Start Price: $26.97 VRX Score: +140.24

Approval of new drug

jsgant13 (99.18) Submitted: 11/15/2010 12:39:38 PM : Start Price: $25.17 VRX Score: +159.79

VALUEACT HOLDING

NoonanR (73.83) Submitted: 9/30/2010 11:42:12 AM : Start Price: $24.00 VRX Score: +166.14

sg

up82870 (< 20) Submitted: 9/26/2010 2:33:44 PM : Start Price: $25.94 VRX Score: +143.84

They are being honest!

rathrbsrfng (52.02) Submitted: 5/17/2010 10:31:28 AM : Start Price: $18.67 VRX Score: +254.80

Good momentum

Beebzer (95.98) Submitted: 5/20/2009 1:34:09 AM : Start Price: $9.12 VRX Score: +636.63

Building a portfolio based on insider cluster buys.

crimfunk (72.92) Submitted: 2/2/2008 1:21:34 AM : Start Price: $4.38 VRX Score: +1,581.48

undervalued, EPS 5 Year Growth (%) 199.82

hennessy7 (49.16) Submitted: 10/10/2007 11:27:13 AM : Start Price: $6.19 VRX Score: +1,094.49

I was long on this stock until my stop loss triggered. Looks like it may trend down before coming back up. Not willing to bet my $ but I will put it on CAPS.